These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9005413)

  • 1. [Increase in TSH levels in thyroid carcinoma patients after withdrawal of suppressive levothyroxine medication].
    Hackländer S; Voth E; Schicha H
    Nuklearmedizin; 1996 Oct; 35(5):170-4. PubMed ID: 9005413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
    Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
    Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial.
    Appelhof BC; Fliers E; Wekking EM; Schene AH; Huyser J; Tijssen JG; Endert E; van Weert HC; Wiersinga WM
    J Clin Endocrinol Metab; 2005 May; 90(5):2666-74. PubMed ID: 15705921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
    Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S
    Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual association between a thyrotropin-secreting pituitary adenoma and a papillary thyroid carcinoma.
    Gasparoni P; Rubello D; Persani L; Beck-Peccoz P
    Thyroid; 1998 Feb; 8(2):181-3. PubMed ID: 9510128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.
    Van Tassell B; Wohlford GF; Linderman JD; Smith S; Yavuz S; Pucino F; Celi FS
    Thyroid; 2019 Oct; 29(10):1371-1379. PubMed ID: 31364488
    [No Abstract]   [Full Text] [Related]  

  • 7. Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma.
    Shakir MK; Krook LS; Schraml FV; Hays JH; Clyde PW
    Thyroid; 2008 Jul; 18(7):787-92. PubMed ID: 18631009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy.
    Verburg FA; Smit JW; Grelle I; Visser TJ; Peeters RP; Reiners C
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):577-81. PubMed ID: 22017394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer.
    Iorcansky S; Herzovich V; Qualey RR; Tuttle RM
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6553-5. PubMed ID: 16174712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of either LT4 monotherapy or LT4/LT3 combined therapy in patients totally thyroidectomized for thyroid cancer.
    Regalbuto C; Maiorana R; Alagona C; Paola RD; Cianci M; Alagona G; Sapienza S; Squatrito S; Pezzino V
    Thyroid; 2007 Apr; 17(4):323-31. PubMed ID: 17465862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism.
    Ringel MD; Ladenson PW
    J Clin Endocrinol Metab; 1996 May; 81(5):1724-5. PubMed ID: 8626823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
    Cooper DS; Specker B; Ho M; Sperling M; Ladenson PW; Ross DS; Ain KB; Bigos ST; Brierley JD; Haugen BR; Klein I; Robbins J; Sherman SI; Taylor T; Maxon HR
    Thyroid; 1998 Sep; 8(9):737-44. PubMed ID: 9777742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart Failure and Stroke Risks in Users of Liothyronine With or Without Levothyroxine Compared with Levothyroxine Alone: A Propensity Score-Matched Analysis.
    Yi W; Kim BH; Kim M; Kim J; Im M; Ryang S; Kim EH; Jeon YK; Kim SS; Kim IJ
    Thyroid; 2022 Jul; 32(7):764-771. PubMed ID: 35570696
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation of patients with thyroid cancer for 131I scintigraphy or therapy by 1-3 weeks of thyroxine discontinuation.
    Grigsby PW; Siegel BA; Bekker S; Clutter WE; Moley JF
    J Nucl Med; 2004 Apr; 45(4):567-70. PubMed ID: 15073251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
    Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life.
    Tariq A; Wert Y; Cheriyath P; Joshi R
    South Med J; 2018 Jun; 111(6):363-369. PubMed ID: 29863229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly sensitive determination of TSH in the follow-up of TSH-suppressive therapy of patients with differentiated thyroid cancer.
    Mann K; Saller B; Mehl U; Hörmann R; Moser E
    Nuklearmedizin; 1988 Feb; 27(1):24-8. PubMed ID: 3368333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postintervention serum TSH levels may be useful to differentiate patients who should undergo levothyroxine suppressive therapy after thyroid surgery for multinodular goiter in a region with moderate iodine deficiency.
    Rotondi M; Amato G; Del Buono A; Mazziotti G; Manganella G; Biondi B; Sinisi AM; Santini L; Bellastella A; Carella C
    Thyroid; 2000 Dec; 10(12):1081-5. PubMed ID: 11201853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer.
    Montesano T; Durante C; Attard M; Crocetti U; Meringolo D; Bruno R; Tumino S; Rubello D; Al-Nahhas A; Colandrea M; Maranghi M; Travascio L; Ronga G; Torlontano M
    Biomed Pharmacother; 2007 Sep; 61(8):468-71. PubMed ID: 17553654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.